<DOC>
	<DOCNO>NCT02704624</DOCNO>
	<brief_summary>Thus , aim current study ass influence vitamin D deficiency , consequently , serum calcium deficiency body composition , muscular activity , bone mineral density , fatigue , exercise tolerance CD patient . Secondly , also aim determine impact vitamin D supplementation population .</brief_summary>
	<brief_title>Effects Supplementation Vitamin D Patients With Crohn ` Disease</brief_title>
	<detailed_description>This clinical , randomize , control , double-blind trial comprise consecutive sample 110 CD patient remission treat Gastroenterology team Inflammatory Intestinal Disease Clinic University Hospital ( HU/CAS ) , Federal University Juiz de Fora ( UFJF ) . The patient divide two group : 55 patient low serum vitamin D level 55 patient normal vitamin D level . Upon approval Ethics Committee UFJF , study aim procedures previously explain individual , sign inform consent form . The sample size base handgrip strength test REF , assume alpha risk 5 % beta risk 80 % , standard deviation 2.5 , difference magnitude 30 % response intervention placebo control group , sample size need 45 patient group . Therefore , consider potential loss , 55 patient recruit group , require total 110 volunteer . Study procedure Phase 1 . Assessment All patient study subject follow test : a. clinical assessment ; B. biochemical assessment ; c. body composition assessment/anthropometry ; d. bone mineral density assessment ; e. peripheral muscle strength assessment ; f. fatigue assessment ; g.Exercise Tolerance Testing Clinical Assessment Disease The following data collect initial assessment : age , gender , CD duration , data related Montreal Classification ( age time diagnosis , disease behavior location ) , glucocorticoid use number exacerbation previous year . The inflammatory activity assessment hold accord Harvey-Bradshaw Index , When score less 5 , disease consider inactive . Biochemical Assessment The participant instruct fast 12 hour prior blood sample analysis . A stool sample well 5 ml venous blood sample collect patient order determine biochemical parameter . The University Hospital routine laboratory analyze venous blood , level C-reactive protein ( CRP ) , calcium , 25-hydroxyvitamin D , parathyroid hormone ( PTH ) inflammatory cytokine Interleukins ( IL ) 17 , IL 6 Tumor necrosis factor alfa ( TNF-α ) . Fecal calprotectin dosage perform stool sample . CRP serum calcium routinely evaluate CD patient follow-up inflammatory bowel disease clinic HU/CAS . The following reference value take consideration regard 25-hydroxyvitamin D : &lt; 20ng/mL = deficiency , 21 29 ng/mL = insufficiency , &gt; 30 ng/mL = satisfactory . Bone Mineral Density Assessment A bone densitometer , Lunar Prodigy Primo ( pr + 351035 ) , used measure patient ' bone mineral density ( BMD ) , express g/cm2 , dual-energy x-ray absorptiometry ( DXA ) . The double-energy X-ray densitometry skeleton specific sit spine hip base X-rays absorption calcium crystal bone . The lumbar spine region L1 L4 total proximal femur assess . The examination hold appropriate condition , accord technical quality control . The coefficient variation lumbar spine total proximal femur obtain base result . The low BMD define reduction great -2.0 standard deviation reference value mean healthy individual , adjust accord height , age gender ( Z score ) , compliance official position International Society Clinical Densitometry ( ISCD ) . Body Composition Assessment/Anthropometry The assessment hold Quantum BIA ( bioelectrical impedance analysis ) bioimpedance device . The device four-pole , digital display , provide resistance reactance value . Total segmental body composition parameter also assess DXA express kg . Muscle Strength Assessment The peripheral muscle strength assess maximum voluntary handgrip strength use hand-held dynamometry ( HHD ) , consist simple objective test estimate skeletal muscle function . The Jamar 's hydraulic dynamometer use , since recommend American Society Hand Therapists ( ASHT ) consider accurate precise instrument use ass HHD . Fatigue Assessment The questionnaire Chalder et al . ( Annex ) , validate Brazil apply assess fatigue . Exercise Tolerance Testing The exercise capacity assess walk test progressive load Shuttle Walk Test . Phase 2 . Intervention A double-blind , randomize , placebo-controlled study perform . After evaluation serum vitamin D level , intervention-group-selected patient present deficient insufficient level receive vitamin D supplementation least six month well nutritional instruction experience nutritionist regard consumption vitamin-D-and-calcium-rich food . The supplementation perform patient serum vitamin D level 29 ng/Ml . The replacement cholecalciferol ( vitamin D3 ) tablet provide cost patient . The dosage 1.500-2.000 IU ( International Units ) vitamin D/day recommend order meet need vitamin D 30ng/ml adult . However , dose least 2 3 time higher recommended CD patient due malabsorption , significant loss adipose tissue use glucocorticoid . Thus , dose 50000IU/week administer . The contraindication precaution use vitamin D respect , namely : hypersensitivity D-group vitamin , hypercalcemia , hypercalciuria metastatic calcification ; interaction digitalis , thiazide , anticonvulsant antacid medication . Despite possible interference skin melanin concentration vitamin D absorption , evidence find support differentiate supplementation Afro descendant Caucasian individual . The patient select placebo group receive inert content tablet without therapeutic effect . After study completion , control patient receive complete treatment hypovitaminosis D. Throughout intervention phase , treat group control group patient monitor phone every 15 day order optimize adhesion . Phase 3 . Reassessment At end 6 month supplementation cholecalciferol ( vitamin D3 ) , subgroup patient subject assessment perform phase 1 .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Sarcopenia</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Paresis</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Clinical diagnosis Crohn 's Disease ( moderate severe ) Remission Crohn 's activity Reduced blood level vitamin D Presence chronic concomitant disease Presence autoimmune disease Presence sleep disturbance Abuse alcohol drug Pregnancy lactation , climacteric and/or menopausal woman Adherence extreme diet ( e.g . macrobiotic vegetarian diet ) Celiac disease Presence extensive resection small intestine ( 100cm² ) Patients undergo vitamin D replacement last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Crohn Disease</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Exercise Tolerance</keyword>
	<keyword>Vitamin</keyword>
</DOC>